EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Cell Surface Engineering by Phase‐Separated Coacervates for Antibody Display and Targeted Cancer Cell Therapy

Hongfei Chen, Yishu Bao, Xiaojing Li, Fangke Chen, Ryohichi Sugimura, Xiangze Zeng, Jiang Xia iD

Angewandte Chemie International Edition · 24.10.2024 · 63 (44)

DOI: 10.1002/anie.202410566 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Angewandte Chemie International Edition, online erschienen am 25.09.2024. Verfasst von Hongfei Chen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry and Center for Cell & Developmental Biology, The Chinese University of Hong Kong, Shatin, 99999, Hong Kong SAR, China. Hauptthemen laut MEDLINE: Killer Cells, Natural. Die Arbeit wurde bisher 43-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: University Grants Committee, Research Impact Fund, CUHK (ICSG, CRIMS, and Direct Grant).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cell therapies such as CAR−T have demonstrated significant clinical successes, driving the investigation of immune cell surface engineering using natural and synthetic materials to enhance their therapeutic performance. However, many of these materials do not fully replicate the dynamic nature of the extracellular matrix (ECM). This study presents a cell surface engineering strategy that utilizes phase‐separated peptide coacervates to decorate the surface of immune cells. We meticulously designed a tripeptide, Fmoc−Lys−Gly−Dopa−OH (KGdelta; Fmoc=fluorenylmethyloxycarbonyl; delta=Dopa, dihydroxyphenylalanine), that forms coacervates in aqueous solution via phase separation. These coacervates, mirroring the phase separation properties of ECM proteins, coat the natural killer (NK) cell surface with the assistance of Fe 3+ ions and create an outer layer capable of encapsulating monoclonal antibodies (mAb), such as Trastuzumab. The antibody‐embedded coacervate layer equips the NK cells with the ability to recognize cancer cells and eliminate them through enhanced antibody‐dependent cellular cytotoxicity (ADCC). This work thus presents a unique strategy of cell surface functionalization and demonstrates its use in displaying cancer‐targeting mAb for cancer therapies, highlighting its potential application in the field of cancer therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Killer Cells, NaturalHumansNeoplasmsTrastuzumabAntibodies, MonoclonalOligopeptidesCell EngineeringCell Line, TumorCell- and Tissue-Based Therapy

Stichwörter der Autor:innen

Cell surface engineeringcancer therapycoacervatenatural killer cellsphase separation

Substanzen

TrastuzumabAntibodies, MonoclonalOligopeptides

Autor:innen und Institutionen

  • Department of Chemistry and Center for Cell & Developmental Biology, The Chinese University of Hong Kong, Shatin, 99999, Hong Kong SAR, China.
  • Department of Physics, Hong Kong Baptist University, Kowloon Tong, 99999, Hong Kong SAR, China.
  • School of Biomedical Sciences, The University of Hong Kong, Hong Kong, 99999, Hong Kong SAR, China.

ORCID-Profile: Jiang Xia

Förderung

  • University Grants Committee
  • Research Impact Fund
  • CUHK (ICSG, CRIMS, and Direct Grant)
  • National Natural Science Foundation of China

Zitieren

APA

Chen, H., Bao, Y., Li, X., Chen, F., Sugimura, R., Zeng, X., & Xia, J. (2024). Cell Surface Engineering by Phase‐Separated Coacervates for Antibody Display and Targeted Cancer Cell Therapy. Angewandte Chemie International Edition, 63(44). https://doi.org/10.1002/anie.202410566

Vancouver

Chen H, Bao Y, Li X, Chen F, Sugimura R, Zeng X, et al. Cell Surface Engineering by Phase‐Separated Coacervates for Antibody Display and Targeted Cancer Cell Therapy. Angewandte Chemie International Edition. 2024;63(44). doi:10.1002/anie.202410566

BibTeX
@article{Chen2024,
  author = {Chen, Hongfei and Bao, Yishu and Li, Xiaojing and Chen, Fangke and Sugimura, Ryohichi and Zeng, Xiangze and Xia, Jiang},
  title = {Cell Surface Engineering by Phase‐Separated Coacervates for Antibody Display and Targeted Cancer Cell Therapy},
  journal = {Angewandte Chemie International Edition},
  year = {2024},
  volume = {63},
  number = {44},
  doi = {10.1002/anie.202410566}
}
Kostenlos starten →